300272 开能健康
2026/09 - 九个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入1,372,320-0.82%1,840,9531,724,2551,671,6991,660,642
减:营业总成本1,259,4682.01%1,681,4001,578,6381,518,2421,533,856
    其中:营业成本826,275-1.33%1,122,5831,053,0551,044,2881,096,817
               财务费用48,558108.72%37,7913,3058,13911,078
               资产减值损失(791)-38.75%(1,962)(7,057)(5,295)(23,594)
公允价值变动收益(58,068)180,566.58%(14,054)(3,001)27,1227,362
投资收益(21,363)2.99%(41,828)(22,492)(22,461)(4,763)
    其中:对联营企业和合营企业的投资收益(21,730)1.67%(42,458)(22,641)(20,398)(6,638)
营业利润40,856-69.86%110,291126,846161,807113,004
利润总额42,751-68.26%110,192121,747158,805114,273
减:所得税费用24,3971.92%30,12021,4875,32815,239
净利润18,354-83.43%80,071100,260153,47899,034
减:非控股权益30,09324.88%24,06229,87321,0316,472
股东净利润(11,739)-113.55%56,00970,387132,44792,562

市场价值指针
每股收益 (元) *-0.019-112.64%0.0970.1240.2360.160
每股派息 (元) *----0.1800.1600.1550.100
每股净资产 (元) *1.984-15.56%2.0621.9782.1101.889
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容